QuVa Pharma, Inc.: 22 recalls on record

Recalls filed with 1 agency: FDA (22).

First recall on record: July 13, 2016. Most recent: July 15, 2026.

Risk classification: Class I: 2 · Class II: 17 · Class III: 3

Most recent recalls

DateAgencyProduct
July 15, 2026FDAMethohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded dr…D-0664-2026
November 5, 2025FDAR.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl, and Ketorolac Tromethamine) in Sod…D-0113-2026
April 2, 2025FDAfentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/m…D-0295-2025
April 2, 2025FDAfentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25…D-0296-2025
April 2, 2025FDAfentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/m…D-0297-2025
October 5, 2022FDAoxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride, Injection for IV …D-1544-2022
July 1, 2020FDAR.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 …D-1335-2020
June 17, 2020FDAoxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV U…D-1302-2020
December 11, 2019FDAfentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) in 0.9% S…D-0565-2020
December 11, 2019FDAfentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe, Preservative Free, Rx, QuVA Pharma 107…D-0558-2020
December 11, 2019FDAfentaNYL 2500 mcg/50 mL (50 mcg/mL) 50 mL bag, Preservative Free, Rx, QuVA Pharma 1075 We…D-0569-2020
December 11, 2019FDAfentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL (1.667 mg/mL) …D-0568-2020
December 11, 2019FDAfentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride, 100 mL Bag, Preservative Fr…D-0563-2020
December 11, 2019FDAfentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free,…D-0567-2020
December 11, 2019FDAfentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe Preservative Fre…D-0572-2020
December 11, 2019FDAfentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% S…D-0561-2020
December 11, 2019FDAfentaNYL 400 mcg/200 mL (2 mcg/mL) 0.1% ROPivacaine HCl 200 mg/200 mL (1 mg/mL) in 0.9% S…D-0562-2020
December 11, 2019FDAfentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.1% 200 mg/200 mL (1 mg/mL) in 0.9% S…D-0564-2020
December 11, 2019FDAfentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% S…D-0548-2020
December 19, 2018FDANorepinephrine 8 mg (32 mcg/mL) added to 0.9% Sodium Chloride Injection 250 mL Bag, Rx on…D-0295-2019
September 26, 2018FDANorepinephrine 4 mg (16 mcg/mL) added to 5% Dextrose 250 mL Bag Preservative Free, Rx onl…D-0003-2019
July 13, 2016FDAPHENYLephrine 1 mg/10 mL (100 mcg/mL) in 0.9% Sodium Chloride, 10 mL syringe, packaged in…D-1066-2016

Questions about this company

How many recalls does QuVa Pharma, Inc. have?
Recalert has 22 U.S. recalls on record for QuVa Pharma, Inc., published between July 13, 2016 and July 15, 2026.
What was the most recent QuVa Pharma, Inc. recall?
FDA recall D-0664-2026, published July 15, 2026: Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46.
Which agencies have handled QuVa Pharma, Inc. recalls?
QuVa Pharma, Inc. appears as the recalling firm in recalls from: FDA (22).

Do you carry products from QuVa Pharma, Inc.? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related companies